ImmuPharma plc (LON:IMM – Get Free Report)’s share price was down 5.3% during mid-day trading on Wednesday . The stock traded as low as GBX 5.04 ($0.06) and last traded at GBX 5.59 ($0.07). Approximately 46,394,512 shares were traded during mid-day trading, an increase of 88% from the average daily volume of 24,729,924 shares. The stock had previously closed at GBX 5.90 ($0.07).
ImmuPharma Trading Down 20.0 %
The stock has a market capitalization of £19.66 million, a PE ratio of -472.00 and a beta of 1.53. The business’s 50 day moving average is GBX 1.92 and its 200 day moving average is GBX 1.78.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Further Reading
- Five stocks we like better than ImmuPharma
- The Risks of Owning Bonds
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- How to Use the MarketBeat Dividend Calculator
- What Does the Future Hold for Eli Lilly?
- What Do S&P 500 Stocks Tell Investors About the Market?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
